echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Radiol: Prediction of MYCN expansion in neuroblastoma based on CT radiomics

    Eur Radiol: Prediction of MYCN expansion in neuroblastoma based on CT radiomics

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuroblastoma is the most common extracranial solid tumor in children .


    Neuroblastoma is the most common extracranial solid tumor in children .


    Radiogenomics focuses on detecting the correlation between image features and genomic data.


    Recently, a study published in the journal European Radiology constructed CT-based radioomics features and evaluated its diagnostic performance in predicting MYCN amplification (MNA) in children with neuroblastoma , establishing a non-invasive approach for the clinic Methods of detecting and evaluating MNA provide the possibility.


    The study included 78 children with neuroblastoma (55 cases in the training cohort, 23 cases in the experimental cohort).


    The study included 78 children with neuroblastoma (55 cases in the training cohort, 23 cases in the experimental cohort).


    Figure 1 ROC curve (blue line) and clinical radiomic nomogram (red line) of the clinical model.


    Figure 1 ROC curve (blue line) and clinical radiomic nomogram (red line) of the clinical model.


    Figure 2 Decision curve analysis (DCA) (blue line) and clinical radioomics nomogram (red line) of the clinical model.


    Figure 2 Decision curve analysis (DCA) (blue line) and clinical radioomics nomogram (red line) of the clinical model.


    The CT-based radioomics features can predict MNA.


    Original source:

    Haoting Wu,Chenqing Wu,Hui Zheng,et al.


    Wu Haoting, Chenqing Wu, Hui Zheng, et Al Radiogenomics of neuroblastoma in Pediatric patients:.
    CT-based radiomics Signature of MYCN in Predicting amplification.
    DOI: org/10.
    1007/s00330-020-07246-1">10.
    1007 / s00330-020-07246-1org/10.
    1007/s00330-020-07246-1"> 10.
    1007 / s00330-020-07246-1 in This message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.